Lv12
36 积分 2025-09-01 加入
Selective Targeting of STAT6: Recent Advances and Future Perspectives
6小时前
已完结
Discovery of RP-37 analogues as potent, selective irreversible inhibitors targeting DNA polymerase theta (POLθ)
6小时前
已完结
In vivo CAR engineering for immunotherapy
7天前
已完结
A guide to CAR T cell therapies: development, current status and future prospects
7天前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
10天前
已完结
Erythrocyte–antibody conjugates to overcome immunotherapy resistance
10天前
已完结
Erythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
10天前
已完结
Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021
4个月前
已完结
Exploring the next generation of antibody–drug conjugates
5个月前
已完结
Antibody–oligonucleotide conjugates enter the clinic
5个月前
已完结
皖公网安备34019202002308
